Get our Newsletter
Sign up to receive the Pet Perspective, a monthly e-newsletter filled with videos and articles about pet health and other fun topics.
We are looking for client-owned dogs that are demonstrating signs of arthritis to be enrolled in a study to evaluate a novel once-weekly treatment.
The study is fully funded for the duration of the study including study drug and all study related procedures. Dogs who complete the study will be provided a 6-month supply of chondroitin-containing neutraceutical to promote joint health.
To qualify, dogs must meet all of these criteria:
Demonstrate signs of arthritis such as lameness or difficulty walking
Must not have received corticosteroids or non-steroidal anti-inflammatory medications for 2 months
Must otherwise be in general good health
Owners must be able to present their dogs for evaluation and treatment over a two- to three-month period of time.